Tagged: Pharmaceuticals

The Data Divide: Managing the Misalignment in Canada’s Evidentiary Requirements for Drug Regulation and Funding

Articles / Forthcoming Articles

“The Data Divide: Managing the Misalignment in Canada’s Evidentiary Requirements for Drug Regulation and Funding” (with Patrick Dyke) (2011) – accepted by UBC Law Review. PR. 33 pages (in Word format) Canadian expenditure on pharmaceutical drugs is skyrocketing at a rate which outstrips every other major health care spending category. This is a product of many diverse factors, foremost of which is the glut of ‘me-too’ drugs which provide little or no...

Drug Promotion, Quality and Patient Safety

Invited Presentations / Presentations at Meetings and Symposia

Presented opening remarks at the symposium on “Drug Promotion, Quality and Patient Safety”. The aim of the symposium was to provide researchers and policy-makers an opportunity to explore drug promotion regulation in terms of quality of information and impacts on patient safety. It also included discussion of the results of a comparative study examining the quality of information provided to primary care physicians by pharmaceutical sales representatives in the United States, France and Canada. November...

Collen M. Flood
Fetch Tweets: Could not authenticate you. Code: 32

Speaking Engagements

  • No Events